Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
Stefan Ambs(University of Maryland, Baltimore), Carlo M. Croce(The Ohio State University), Robyn L. Prueitt(Gradient (United States)), Stefano Volinia(University of Ferrara), Harris G. Yfantis(University of Maryland, Baltimore), Fabio Petrocca(Bristol-Myers Squibb (Sweden)), Tiffany A. Wallace(University of Florida), Ming Yi(Science Applications International Corporation (United States)), Robert M. Stephens(National Cancer Institute), George A. Calin(The University of Texas MD Anderson Cancer Center), Robert Hudson(National Cancer Institute), Chang‐Gong Liu, Tiffany M. Howe(National Cancer Institute)
Cited by 708
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
|Proceedings of the National Academy of Sciences|2004|1.3k